Fevipiprant, a prostaglandin D2 receptor 2 antagonist, in patients with persistent eosinophilic asthma: a single-centre, randomised, double-blind, parallel-group, placebo-controlled trial
Titel:
Fevipiprant, a prostaglandin D2 receptor 2 antagonist, in patients with persistent eosinophilic asthma: a single-centre, randomised, double-blind, parallel-group, placebo-controlled trial
Auteur:
Gonem, Sherif Berair, Rachid Singapuri, Amisha Hartley, Ruth Laurencin, Marie F M Bacher, Gerald Holzhauer, Björn Bourne, Michelle Mistry, Vijay Pavord, Ian D Mansur, Adel H Wardlaw, Andrew J Siddiqui, Salman H Kay, Richard A Brightling, Christopher E